/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
RetinalGenix Technologies Inc. ( RetinalGenix or the Company ) is an ophthalmic research and development company focused on developing technologies to screen, provide information and treat eye health disorders (ophthalmic, optical, and sight-threatening disorders), Our devices described below are designed to facilitate the early detection of such diseases and empowering patients and their clini…
$4.00
+$0.01 (+0.25%)
EOD Sep 18, 2026
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$2M
▲ +43.8% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$478K
▲ +24.7% YoY
Net Debt
$76K
Cash & Equiv.
$27K
Continue Research
SourceComputed from the 10-Q filed 14 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 15 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.